DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Chen J, Kinoshita T, Sukbuntherng J, Chang BY, Elias L.
Ibrutinib inhibits ERBB receptor tyrosine kinases and HER2-amplified breast cancer cell growth.
Mol Cancer Ther 2016;
15: 2835-44
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.